Katherine S Bowdish Net Worth & Insider Trades
Katherine S Bowdish - Senior Vice President, Alexion Pharmaceuticals Inc
What is Katherine S Bowdish's Net Worth?
The current estimated net worth of Alexion Pharmaceuticals Inc's Senior Vice President, Katherine S Bowdish, is estimated to be about $1.18M . Katherine S Bowdish owns about 40,196 units of Alexion Pharmaceuticals Inc common stock. In the last year at Alexion Pharmaceuticals Inc, Katherine S Bowdish has sold an estimated value of $318.51K worth.
What is Katherine S Bowdish's Past Insider Trading?
Katherine S Bowdish's largest sale order was 5,000 units , worth over $120.48K on December 16, 2004. In total, Katherine S Bowdish has made about 5 transactions over a year of their time at Alexion Pharmaceuticals Inc. Katherine S Bowdish usually trades in June, April, February, July and December, with the busiest year in 2004. The most recent transaction was a sale order of 3,000 units , worth over $64.72K on June 15, 2005.
Katherine S Bowdish
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Katherine S Bowdish's' Mailing Address?
- Mailing address is C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410 CT
Alexion Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Ludwig Hantson | 2019 | $1,250,000 | - | $15,243,634 | - | $2,430,000 | $24,350 | $18,947,984 |
| Ludwig Hantson | 2018 | $1,200,000 | - | $12,385,168 | - | $2,880,000 | $25,082 | $16,490,250 |
| Ludwig Hantson | 2017 | $900,000 | - | $9,618,758 | $2,282,881 | $2,275,000 | $233,428 | $15,310,067 |
| Aradhana Sarin | 2019 | $651,764 | - | $3,380,763 | - | $813,011 | $31,604 | $4,877,142 |
| Paul Clancy | 2019 | $927,000 | - | $3,863,694 | - | $1,051,218 | $23,832 | $5,865,744 |
| Paul Clancy | 2018 | $900,000 | - | $3,302,761 | - | $1,260,000 | $23,752 | $5,486,513 |
| Paul Clancy | 2017 | $415,385 | $500,000 | $8,799,954 | $1,220,082 | $473,620 | $2,262 | $11,411,303 |
| Brian Goff | 2019 | $740,000 | - | $3,863,694 | - | $923,076 | $20,240 | $5,547,010 |
| Brian Goff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $111,873 | $4,876,796 |
| Brian Goff | 2017 | $381,634 | $100,000 | $2,390,026 | $732,899 | $434,380 | $58,787 | $4,097,726 |
| Anne-Marie Law | 2019 | $695,000 | - | $3,622,303 | - | $788,130 | $33,528 | $5,138,961 |
| Anne-Marie Law | 2018 | $650,000 | - | $2,889,885 | - | $910,000 | $846,604 | $5,296,489 |
| Anne-Marie Law | 2017 | $362,500 | $200,000 | $2,300,015 | - | $410,472 | $68,710 | $3,341,697 |
| John Orloff | 2019 | $770,000 | - | $3,863,694 | - | $960,498 | $32,550 | $5,626,742 |
| John Orloff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $98,679 | $4,863,602 |
| John Orloff | 2017 | $376,442 | $200,000 | $2,499,995 | - | $472,500 | $80,351 | $3,629,288 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm
What are Alexion Pharmaceuticals Inc's Past Insider Trades?
Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director, Stephen Squinto, EVP, and Vikas Sinha, EVP & CFO .
ALEXION PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||